I think it interesting that one of the directors increased his interest through a private company about September 2018. I think the purchases were about $400,000. He must have some confidence. Technogas has only been used on a limited type of procedure, lung function. From my understanding, ther is now also a market for diagnosis in relation to pulmonary embolism which is quite a separate area. If the approvals come through, the longer terms sales prospects are enhanced. It seems as if the US FDA approval process is a likely catalyst for increasing sales.
I think it interesting that one of the directors increased his...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
0.005(0.35%) |
Mkt cap ! $157.2M | |||
| Open | High | Low | Value | Volume |
| $1.42 | $1.42 | $1.41 | $14.02K | 9.894K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2483 | $1.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.43 | 2415 | 1 |
View Market Depth
| Last trade - 15.59pm 16/08/2024 (20 minute delay) ? |
| CYC (ASX) Chart |